0
Abstract: Poster Presentations |

RISK FACTORS OF METABOLIC SYNDROME IN MALE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE FREE TO VIEW

Sang-Ha Kim, PhD*; Nakwon Lee, MD; Sun Nyung Lee, MD; Won Yeon Lee, PhD; Suk Joong Yong, PhD; Kye Chul Shin, PhD
Author and Funding Information

Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea


Chest


Chest. 2009;136(4_MeetingAbstracts):118S-c-119S. doi:10.1378/chest.136.4_MeetingAbstracts.118S-c
Text Size: A A A
Published online

Abstract

PURPOSE:  Chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MeS) are common chronic disease with increasing prevalence. One of the main causes of death with COPD has been cardiovascular disease. This study was undertaken to evaluate the clinical characteristics and the risk factors for MeS in male patients with COPD.

METHODS:  The 1,879 male subjects (aged 40–70 years) were enrolled in this survey participated in the Korean Rural Genomic Cohort study. They were devided into four groups depending on the presence of MeS and COPD (group1 = normal control without MeS, group2 = normal control with MeS, group3 = COPD without MeS, group4 = COPD with MeS). COPD was defined as a FEV1/FVC ratio < 0.7 and MeS was defined according to the criteria of National Cholesterol Education Programme's Adult Treatment Panel III. Spirometry was performed according to American Thoracic Society recommendations. Body composition analysis was measured by bioelectrical impedance. C-reactive protein (CRP), leptin and adiponectin were measured.

RESULTS:  Among the COPD patients, body mass index (BMI), fat free mass index (FFMI), visceral fat mass index (VFMI) and waist circumference (WC) were more increased in group4 than group3 significantly (p < 0.001, p < 0.001, p < 0.001, and p < 0.001, respectively). As inflammatory markers, the levels of leptin were higher in group4 than group3 (p < 0.001) and those of adiponectin were lower in group4 than group3, significantly (p < 0.001). The ratio of leptin/adiponectin was significantly higher in group4 than group3 (p < 0.001). Adjusted odds ratio of leptin and leptin/adiponectin ratio for MeS in COPD patients were 1.16 (95%CI 1.01–1.32) and 1.98 (95%CI 1.11–3.53) respectively.

CONCLUSION:  The levels of leptin and leptin/adiponectin ratio may be useful markers for prediction of MeS in male COPD patients.

CLINICAL IMPLICATIONS:  Measurement of the level of leptin and adiponectin may be useful to detect the risk group for MeS in COPD patients. It would be important for reducing the morbidity and mortality due to cardiovascular diseases in COPD patients.

DISCLOSURE:  Sang-Ha Kim, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, November 4, 2009

12:45 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543